5-cyclopropyl-N-[1-[[4-(3,3,3-trifluoropropylamino)cyclohexyl]methylsulfonyl]piperidin-4-yl]-1,2-oxazole-3-carboxamide
C22H33F3N4O4S — CID 155566734
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-cyclopropyl-N-[1-[[4-(3,3,3-trifluoropropylamino)cyclohexyl]methylsulfonyl]piperidin-4-yl]-1,2-oxazole-3-carboxamide
5-cyclopropyl-N-[1-[[4-(3,3,3-trifluoropropylamino)cyclohexyl]methylsulfonyl]piperidin-4-yl]-1,2-oxazole-3-carboxamide (PubChem CID 155566734) has the molecular formula C22H33F3N4O4S and a molecular weight of 506.59 g/mol. Its IUPAC name is 5-cyclopropyl-N-[1-[[4-(3,3,3-trifluoropropylamino)cyclohexyl]methylsulfonyl]piperidin-4-yl]-1,2-oxazole-3-carboxamide.
Molecular Properties
| Compound Name | 5-cyclopropyl-N-[1-[[4-(3,3,3-trifluoropropylamino)cyclohexyl]methylsulfonyl]piperidin-4-yl]-1,2-oxazole-3-carboxamide |
|---|---|
| PubChem CID | 155566734 |
| Molecular Formula | C22H33F3N4O4S |
| Molecular Weight | 506.59 g/mol |
| Exact Mass | 506.22 |
| IUPAC Name | 5-cyclopropyl-N-[1-[[4-(3,3,3-trifluoropropylamino)cyclohexyl]methylsulfonyl]piperidin-4-yl]-1,2-oxazole-3-carboxamide |
| SMILES | O=C(NC1CCN(S(=O)(=O)CC2CCC(NCCC(F)(F)F)CC2)CC1)c1cc(C2CC2)on1 |
| InChI | InChI=1S/C22H33F3N4O4S/c23-22(24,25)9-10-26-17-5-1-15(2-6-17)14-34(31,32)29-11-7-18(8-12-29)27-21(30)19-13-20(33-28-19)16-3-4-16/h13,15-18,26H,1-12,14H2,(H,27,30) |
| InChIKey | PLOCIYCXSGMYJN-UHFFFAOYSA-N |
| XLogP | 3.18 |
| TPSA | 104.54 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.59 |
| LogP ≤ 5 | 3.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155566734 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.